There's a reason 90% of our clients are emerging biotechs

Medpace CRO is Trusted by Biotech®

There’s a reason 90% of our clients are
emerging biotechs.

While Medpace has grown over the last 30 years, the way we work with biotechs has not changed:

• We remain committed to being Trusted by Biotech®, which translates to keeping our culture and operating structure designed to accommodate efficient partnering, which is crucial for emerging biotechs with limited resources or experience.
• Our purposeful, organic growth provides consistency in leadership, deep institution experience, and incomparable efficiencies, allowing your compound the attention it deserves.
• We continue to expand our global reach and therapeutic expertise, providing resources to advance your medical therapeutic in any region.

Biotechs need a CRO that will give their program the attention it deserves. Medpace has prioritized biotechs for over three decades; we draw on our experience to create the best team and solution for you because at Medpace, we share the same commitment to your compound that you do.